This news release is available only to verified logged-in journalists until the embargo expires on 1/25/2025 3:00:00 PM. Professional journalists may apply for a PressPass to access embargoed stories.
https%3A%2F%2Fwww.newswise.com%2Farticles%2Fcombination-of-dual-targeted-therapies-and-chemotherapy-shows-high-response-rates-in-braf-mutated-metastatic-colorectal-cancer%2F%3Fsc%3Drsla
